# US 2025/0012785 A1 · Systems and methods for detection and quantification of double-stranded rna

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0012785 A1
- Document ID: US20250012785A1
- Status: Published application
- Kind: A1
- Application number: 18/735,719
- Filed: 2024-06-06
- Published: 2025-01-09
- Earliest claimed: 2023-06-06
- Assignees: Promega Corporation
- Applicants: Promega Corporation
- Inventors: Jamison GRAILER; Richard A. Moravec; James R. Hartnett; Mei Cong
- Web page: https://patentgrep.com/patent/US20250012785A1

## CPC

- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- C07K 14/43595: {from coelenteratae, e.g. medusae}
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 9/12: transferring phosphorus containing groups, e.g. kinases (2.7)
- C12Y 113/12013: Oplophorus-luciferin 2-monooxygenase (1.13.12.13)
- C12Y 207/11001: Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- C07K 2319/61: containing an enzyme fusion for detection (lacZ, luciferase)
- C12Q 2522/101: Single or double stranded nucleic acid binding proteins
- C12Q 2525/161: incorporating target specific and non-target specific sites
- G01N 2470/06: Second binding partner specifically binding complex of analyte with first binding partner
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Provided herein are compositions comprising a double-stranded RNA (dsRNA) binding domains linked to components of a complementation system. Upon binding of a pair of dsRNA binding domains to a dsRNA, a detectable complex of the complementation components is formed, and the dsRNA can be detected/quantified.

## Claims

### Claim 1

A double-stranded RNA (dsRNA) detection system comprising:
(a) a first fusion of (i) a first dsRNA binding domain and (ii) a first component of a detectable complex; and
(b) a second fusion of (i) a second dsRNA binding domain and (ii) a second component of the detectable complex;
wherein the first and second components of the detectable complex exhibit low affinity for one another in the absence of facilitation through the binding of the first and second dsRNA binding domains to the dsRNA; and
wherein the first and second components of the detectable complex exhibit low affinity for one another in the absence of facilitation through the binding of the first and second dsRNA binding domains to the dsRNA.

### Claim at position 2

2-10. (canceled)

### Claim 11 (depends on 1)

The system of claim 1, wherein the first and second dsRNA binding domains each comprise dsRNA binding motifs having at least 70% sequence identity with SEQ ID NO: 3062 and SEQ ID NO: 3063.

### Claim 12 (depends on 11)

The system of claim 11, wherein the first and second dsRNA binding domains each comprise dsRNA binding motifs of SEQ ID NO: 3062 and SEQ ID NO: 3063.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The system of claim 1, wherein the dsRNA binding domain comprises at least 70% sequence identity with SEQ ID NO: 3061.

### Claim 15 (depends on 14)

The system of claim 14, wherein the dsRNA binding domain comprises SEQ ID NO: 3061.

### Claim 16 (depends on 1)

The system of claim 1, wherein the detectable complex is capable of generating a signal that can be detected and correlated to the amount of dsRNA in a sample with the system.

### Claim 17

(canceled)

### Claim 18 (depends on 16)

The system of claim 16, wherein the signal comprises one or more of fluorescence, luminescence, enzymatic activity, and ligand binding.

### Claim 19 (depends on 1)

The system of claim 1, wherein the first and second components of the detectable complex are fragments of a protein capable of generating a detectable signal, and wherein the detectable complex is capable of generating the detectable signal upon association of the first and second components of the detectable complex.

### Claim at position 12

20-21. (canceled)

### Claim 22 (depends on 19)

The system of claim 19, wherein the protein is a fluorescent protein selected from yellow fluorescent protein (YFP), green fluorescent protein (GFP), cyan fluorescent protein (CFP), red fluorescent protein (RFP), umbelliferone, fluorescein, fluorescein isothiocyanate, rhodamine, dichlorotriazinylamine fluorescein, cyanines, dansyl chloride, phycocyanin, and phycoerythrin.

### Claim at position 14

23-24. (canceled)

### Claim 25 (depends on 19)

The system of claim 19, wherein the detectable signal is enzymatic activity and the protein is selected from beta-lactamase, dihydrofolate reductase (DHFR), focal adhesion kinase (FAK), Gal4, and horseradish peroxidase.

### Claim at position 16

26-29. (canceled)

### Claim 30 (depends on 19)

The system of claim 19, wherein the protein is a luciferase selected from an Oplophorus luciferase, a firefly luciferase, a click beetle luciferase, a Renilla luciferase, cypridina luciferase, an Aequorin photoprotein, and an obelin photoprotein.

### Claim at position 18

31-32. (canceled)

### Claim 33 (depends on 1)

The system of claim 1, wherein the first component of the detectable complex comprises at least 70% sequence identity with SEQ ID NO: 3043 and the first component of the detectable complex comprises at least 70% sequence identity with SEQ ID NO: 3051.

### Claim 34 (depends on 1)

The system of claim 1, wherein the first component of the detectable complex comprises at least 70% sequence identity with SEQ ID NO: 3044 and the first component of the detectable complex comprises at least 70% sequence identity with SEQ ID NO: 3052.

### Claim 35 (depends on 1)

The system of claim 1, wherein the first component of the detectable complex comprises at least 70% sequence identity with SEQ ID NO: 3045 and the first component of the detectable complex comprises at least 70% sequence identity with SEQ ID NO: 3053.

### Claim 36 (depends on 30)

The system of claim 30, further comprising a substrate for the luciferase.

### Claim 37 (depends on 19)

The system of claim 19, wherein the detectable signal is ligand binding.

### Claim 38 (depends on 1)

The system of claim 1, wherein the detectable complex is a modified dehalogenase complex and wherein the first and second components of the modified dehalogenase complex comprise at least 70% sequence identity with first and second fragments of SEQ ID NO: 1.

### Claim 39

(canceled)

### Claim 40 (depends on 38)

The system of claim 38, further comprising a haloalkyl ligand for the modified dehalogenase.

### Claim at position 27

41-42. (canceled)

### Claim 43

A double-stranded RNA (dsRNA) detection system comprising:
(a) a first fusion of (i) a PKR-derived dsRNA binding domain sequence, and (ii) a peptide component of a bioluminescent complex; and
(b) a second fusion of (i) the PKR-derived dsRNA binding domain sequence, and (ii) a polypeptide component of a bioluminescent complex;
wherein upon binding of the PKR-derived dsRNA binding domain sequences to a dsRNA a luminescent complex is formed by structural complementation of the peptide component and the polypeptide component; and
wherein a luminescent signal produced by the luminescent complex in the presence of the dsRNA and a substrate for the luminescent complex is enhanced when compared to a luminescent signal produced in the absence of the dsRNA.

### Claim at position 29

44-55. (canceled)

### Claim 56 (depends on 1)

A method of detecting dsRNA in a sample, the method comprising contacting the sample with a system of claim 1 and detecting a signal from the detectable complex, wherein the amount of signal detected correlates with the amount of dsRNA in the sample.

### Claim 57

(canceled)
